177 related articles for article (PubMed ID: 24169157)
21. Determining the Optimal Timing for Initiation of Adjuvant Chemotherapy After Resection for Stage II and III Colon Cancer.
Sun Z; Adam MA; Kim J; Nussbaum DP; Benrashid E; Mantyh CR; Migaly J
Dis Colon Rectum; 2016 Feb; 59(2):87-93. PubMed ID: 26734965
[TBL] [Abstract][Full Text] [Related]
22. Treatment trends and predictors of adjuvant and neoadjuvant therapy for gastric adenocarcinoma in the United States.
Sherman KL; Merkow RP; Bilimoria KY; Wang CE; Mulcahy MF; Benson AB; Bentrem DJ
Ann Surg Oncol; 2013 Feb; 20(2):362-70. PubMed ID: 22890592
[TBL] [Abstract][Full Text] [Related]
23. Laparoscopic medial-to-lateral approach for the curative resection of right-sided colon cancer.
Liang JT; Lai HS; Lee PH
Ann Surg Oncol; 2007 Jun; 14(6):1878-9. PubMed ID: 17377832
[TBL] [Abstract][Full Text] [Related]
24. The impact of chronic illnesses on the use and effectiveness of adjuvant chemotherapy for colon cancer.
Gross CP; McAvay GJ; Guo Z; Tinetti ME
Cancer; 2007 Jun; 109(12):2410-9. PubMed ID: 17510973
[TBL] [Abstract][Full Text] [Related]
25. Does delay of adjuvant chemotherapy impact survival in patients with resected stage II and III colon adenocarcinoma?
Bayraktar UD; Chen E; Bayraktar S; Sands LR; Marchetti F; Montero AJ; Rocha-Lima CM
Cancer; 2011 Jun; 117(11):2364-70. PubMed ID: 24048783
[TBL] [Abstract][Full Text] [Related]
26. Single-institution experience of adjuvant 5-fluorouracil-based chemotherapy for stage III colon cancer.
Gibbs P; Handolias D; McLaughlin S; Chapman M; Johns J; Faragher I
Intern Med J; 2008 Apr; 38(4):265-9. PubMed ID: 18298558
[TBL] [Abstract][Full Text] [Related]
27. Effect of including cancer-specific variables on risk-adjusted hospital surgical quality comparisons.
Merkow RP; Bentrem DJ; Winchester DP; Stewart AK; Ko CY; Bilimoria KY
Ann Surg Oncol; 2013 Jun; 20(6):1766-73. PubMed ID: 23354565
[TBL] [Abstract][Full Text] [Related]
28. Time trends in chemotherapy (administration and costs) and relative survival in stage III colon cancer patients - a large population-based study from 1990 to 2008.
van den Broek CB; Bastiaannet E; Dekker JW; Portielje JE; de Craen AJ; Elferink MA; van de Velde CJ; Liefers GJ; Kapiteijn E
Acta Oncol; 2013 Jun; 52(5):941-9. PubMed ID: 23145507
[TBL] [Abstract][Full Text] [Related]
29. Adjuvant chemotherapy for stage III colon cancer: does timing matter?
Czaykowski PM; Gill S; Kennecke HF; Gordon VL; Turner D
Dis Colon Rectum; 2011 Sep; 54(9):1082-9. PubMed ID: 21825887
[TBL] [Abstract][Full Text] [Related]
30. Referral patterns and adjuvant chemotherapy use in patients with stage II colon cancer.
Kirkpatrick HM; Aitelli CL; Qin H; Becerra C; Lichliter WE; McCollum AD
Clin Colorectal Cancer; 2010 Jul; 9(3):150-6. PubMed ID: 20643619
[TBL] [Abstract][Full Text] [Related]
31. The efficacy of oral tegafur-uracil as maintenance therapy following intravenous 5-fluorouracil chemotherapy in stage III colon cancer.
Hong KD; Lee SI; Moon HY
Hepatogastroenterology; 2012; 59(113):104-7. PubMed ID: 22251527
[TBL] [Abstract][Full Text] [Related]
32. Comparison of treatment received versus long-standing guidelines for stage III colon and stage II/III rectal cancer patients diagnosed in Alberta, Saskatchewan, and Manitoba in 2004.
Cree M; Tonita J; Turner D; Nugent Z; Alvi R; Barss R; King C; Winget M
Clin Colorectal Cancer; 2009 Jul; 8(3):141-5. PubMed ID: 19632928
[TBL] [Abstract][Full Text] [Related]
33. [Adjuvant chemotherapy for colon cancer].
Dahl O
Tidsskr Nor Laegeforen; 2007 Nov; 127(23):3094-6. PubMed ID: 18049502
[TBL] [Abstract][Full Text] [Related]
34. "Spontaneous," delayed colon and rectal anastomotic complications associated with bevacizumab therapy.
August DA; Serrano D; Poplin E
J Surg Oncol; 2008 Feb; 97(2):180-5. PubMed ID: 18095268
[TBL] [Abstract][Full Text] [Related]
35. Adjuvant chemotherapy for stage III colon cancer in the oldest old: results beyond clinical guidelines.
Abraham A; Habermann EB; Rothenberger DA; Kwaan M; Weinberg AD; Parsons HM; Gupta P; Al-Refaie WB
Cancer; 2013 Jan; 119(2):395-403. PubMed ID: 22806931
[TBL] [Abstract][Full Text] [Related]
36. Laparoscopic colectomy decreases the time to administration of chemotherapy compared with open colectomy.
Poylin V; Curran T; Lee E; Nagle D
Ann Surg Oncol; 2014 Oct; 21(11):3587-91. PubMed ID: 24728824
[TBL] [Abstract][Full Text] [Related]
37. Geographic variation and sociodemographic disparity in the use of oxaliplatin-containing chemotherapy in patients with stage III colon cancer.
Panchal JM; Lairson DR; Chan W; Du XL
Clin Colorectal Cancer; 2013 Jun; 12(2):113-21. PubMed ID: 23137529
[TBL] [Abstract][Full Text] [Related]
38. Randomized trial of adjuvant therapy in colon carcinoma: 10-year results of NSABP protocol C-01.
Smith RE; Colangelo L; Wieand HS; Begovic M; Wolmark N
J Natl Cancer Inst; 2004 Aug; 96(15):1128-32. PubMed ID: 15292384
[TBL] [Abstract][Full Text] [Related]
39. Adjuvant chemotherapy in stage III colon cancer: guideline implementation, patterns of use and outcomes in daily practice in The Netherlands.
van Gils CW; Koopman M; Mol L; Redekop WK; Uyl-de Groot CA; Punt CJ
Acta Oncol; 2012 Jan; 51(1):57-64. PubMed ID: 22122695
[TBL] [Abstract][Full Text] [Related]
40. Delay in Adjuvant Chemotherapy and Survival Advantage in Stage III Colon Cancer.
Turner MC; Farrow NE; Rhodin KE; Sun Z; Adam MA; Mantyh CR; Migaly J
J Am Coll Surg; 2018 Apr; 226(4):670-678. PubMed ID: 29378259
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
